Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 330.36M P/E - EPS this Y -208.00% Ern Qtrly Grth -
Income -40.22M Forward P/E -2.21 EPS next Y - 50D Avg Chg 6.00%
Sales 314k PEG - EPS past 5Y - 200D Avg Chg -6.00%
Dividend N/A Price/Book 1.39 EPS next 5Y - 52W High Chg -60.00%
Recommedations 1.90 Quick Ratio 9.00 Shares Outstanding 167.41M 52W Low Chg 75.00%
Insider Own 9.99% ROA -25.52% Shares Float 127.01M Beta 0.98
Inst Own 28.06% ROE -17.21% Shares Shorted/Prior 5.90M/5.21M Price 1.99
Gross Margin 100.00% Profit Margin - Avg. Volume 992,638 Target Price 10.68
Oper. Margin -186,483.33% Earnings Date May 7 Volume 461,009 Change -2.93%
About ATAI Life Sciences N.V.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its product candidates include COMP360, a proprietary psilocybin which is in Phase 3 program; BPL-003, an intranasal formulation that is in Phase 2a and 2b clinical studies; TRD; VLS-01, an transmucosal film in Phase 1b clinical studies; and ELE-101, a serotonergic psychedelic that is in Phase 1/2a study, for the treatment of treatment resistant depression. The company also develop IBX-210, an intravenous formulation of ibogaine, and DMX-1002, an oral formulation of ibogaine indicated for the treatment of opioid use disorder; EMP-01, an oral formulation of an R-MDMA derivative being developed for the treatment of post-traumatic stress disorder; and EGX-A and EGX-B, psychedelic-like with novel, non-tryptamine structures with differentiated 5-HT receptor pharmacology. In addition, it offers RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; and GRX-917, a deuterated etifoxine for the treatment of generalize anxiety disorder. Further, the company develops PCN-101, a subcutaneous formulation of R-ketamine, as a therapy for psychiatric indications initially focused on TRD; KUR-101, a formulation of deuterated mitragynine for the treatment of OUD; and RLS-01, indicated for treatment resistant depression. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany with offices in New York and London.

ATAI Life Sciences N.V. News
04/24/24 atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
04/17/24 atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
04/01/24 Atai Life Sciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
03/28/24 atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
03/27/24 atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
03/04/24 atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
02/28/24 atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
02/06/24 atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
01/07/24 Weekly Roundup on the Cannabis Sector & Psychedelic Sector
01/04/24 atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics
01/02/24 atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)
11/14/23 atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights
10/10/23 ATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORT
10/06/23 atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit
10/02/23 atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants
09/14/23 Insider Buying: Florian Brand Acquires 40,000 Shares of ATAI Life Sciences NV
09/14/23 atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
09/06/23 atai Life Sciences to Participate in Upcoming September Investor Conferences
08/10/23 atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)
08/08/23 atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
ATAI Chatroom

User Image Artemis13 Posted - 7 hours ago

$ATAI Pilzemafia

User Image Artemis13 Posted - 8 hours ago

$ATAI criminals

User Image Artemis13 Posted - 8 hours ago

$ATAI Fack u

User Image Artemis13 Posted - 12 hours ago

$ATAI need 3 dollar.

User Image AllinBallin Posted - 1 day ago

$ATAI $92 price prediction by the end of may. I’m calling it

User Image ElectricJ Posted - 1 day ago

$ATAI

User Image Artemis13 Posted - 1 day ago

$ATAI go

User Image ElectricJ Posted - 04/30/24

$ATAI holding up well on down market day

User Image EarthGoddess69 Posted - 04/30/24

$WBUY $AI $ATAI $AIRE flying to the moon join the ride $WBUY

User Image Inversecathiewood1 Posted - 04/29/24

$CYBN $CMPS $ATAI Second half of interview, Cody talks about his favorite public drug development companies https://youtu.be/c0q6sboP97s?si=vmQcIHb2Omczs0Ox

User Image gimmecash333 Posted - 04/29/24

$ATAI ok now please stay above 2

User Image eloquence Posted - 04/29/24

$MNMD $CYBN $CMPS $GHRS $ATAI Investing Across the Psychedelic Medicine Ecosystem: An Interview with Cody Shandraw https://youtu.be/c0q6sboP97s

User Image Artemis13 Posted - 04/29/24

$ATAI Pilze lecker

User Image theflynews Posted - 04/25/24

Here's What You Missed in Cannabis, Psychedelics This Week - $ATAI - https://thefly.com/permalinks/entry.php/ATAIid3903675

User Image leLu83 Posted - 04/25/24

$ATAI added some

User Image PsychedStocks Posted - 04/25/24

$CYBN $ATAI $MNMD $IXHL Cybin to Participate at the 27th Annual Milken Institute Global Conference https://ir.cybin.com/investors/news/news-details/2024/Cybin-to-Participate-at-the-27th-Annual-Milken-Institute-Global-Conference/default.aspx

User Image PsychedStocks Posted - 04/24/24

$CYBN $ATAI $MNMD we’re just scratching the surface of what’s possible by using psychedelics to potentially cure mental health disorders. Excited to be here in the long run

User Image Stock_Titan Posted - 04/24/24

$ATAI atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression https://www.stocktitan.net/news/ATAI/atai-life-sciences-announces-dosing-of-first-patient-in-part-2-of-xajfadf5mzin.html

User Image Cashtonll2 Posted - 04/23/24

Hoping $ATAI can hit $2.30 plus and $CMPS $10+ before $cybn drops another 10%

User Image NetworkNewsWire Posted - 04/23/24

Study Says Psychedelics Can Boost Sexual Satisfaction, Functioning $ATAI https://ibn.fm/JzG7s #psychedelicstocks #intimacy

User Image BobBuran Posted - 04/23/24

Tuesday This is the second of two posts showing a total of about 50 of my buy stop orders above the market for today. Already bot past ten minutes: $ROOT $BAND $ATAI #stocks

User Image BobBuran Posted - 04/23/24

Tuesday This is the first of two posts showing a total of about 50 of my buy stop orders above the market for today. Already bot past ten minutes: $ROOT $BAND $ATAI #stocks

User Image gimmecash333 Posted - 04/23/24

$ATAI $5 EOW!

User Image Cashtonll2 Posted - 04/23/24

Pot stocks green, $CMPS $ATAI and $MNMD green.. $CYBN red, can’t draw it up any better 🤣

User Image andrahagi Posted - 04/19/24

$ATAI Honestly this has been a good day / week trade. seems to follow the pattern of going below 1.90 then going up to 2.10 every week / every other week.

User Image andrahagi Posted - 04/19/24

$ATAI Just grabbed more at 1.85..... looking to accumulate more and more below that.

User Image RoyalsLulz Posted - 04/19/24

$ATAI Time to start the accumulation back up. It's going to be slow, watching to see if we break the 200.

User Image wmoller Posted - 04/18/24

$ATAI And my sub-$2 accumulation of Atai can officially re-start...be patient...the massive gains are still 2-4 years out...IMO...although I do see Atai's SP being significantly higher by year-end.

User Image PsychedStocks Posted - 04/18/24

$CYBN $MNMD $ATAI $CMPS $SPY Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry https://ir.cybin.com/investors/news/news-details/2024/Cybin-Announces-Publication-of-Research-Manuscript-in-the-Journal-of-Medicinal-Chemistry/default.aspx

User Image leLu83 Posted - 04/18/24

$ATAI I scooped some in after hours yesterday. F u macro market

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Brand Florian See Remarks See Remarks Nov 16 Buy 1.156 20,000 23,120 130,000 11/20/23
Brand Florian See Remarks See Remarks Mar 29 Buy 1.4794 70,000 103,558 70,000 03/30/23
Apeiron Investment Group Ltd. 10% Owner 10% Owner Apr 18 Buy 5.12 119,637 612,541 1,478,520 04/20/22
Apeiron Investment Group Ltd. 10% Owner 10% Owner Apr 14 Buy 5.19 4,967 25,779 1,358,883 04/18/22
Apeiron Investment Group Ltd. 10% Owner 10% Owner Apr 08 Buy 4.82 111,615 537,984 1,298,719 04/12/22